Health In Tech reports strong Q1 2025 growth with 56% revenue increase and AI-backed underwriting advancements.

Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding. By Joseph Goldstein Cancer researchers examining the use of ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: Good afternoon ladies and gentlemen and thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2024 ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Call Transcript March 27, 2025 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. Operator: ...

Dr Mujeeb Ur Rehman (principal investigator) alongside co-investigators Dr Muhammad Kazim and Dr Richard Smith, attended a ...

Alberbury Young Farmers Club set themselves the huge ‘Peaks ‘n’ Pedals Charity Challenge’ and raised an incredible amount for charity ...

David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical Industry R&D, Drug Develo ...

Jared Simon - President, Manitoba Harvest & Tilray Wellness at Manitoba Harvest Hemp Foods. Thank you for joining today's conference call to discuss Tilray Brands Financial Results for the fiscal 2025 ...

Pancreatic cancer arises from mutations in the DNA of pancreatic cells, leading to uncontrolled growth and tumour formation.

The oft repeated expression of the town and gown meeting to form a robust interplay of knowledge through a symbiotic ...

MGNX earnings call for the period ending December 31, 2024. MacroGenics ( MGNX 3.60%) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...